Our Mission: Improving and Extending the Lives of Patients with Cancer
 
 
 

News & Events

2007 News Archive
 

12/10/2007
Celator® Pharmaceuticals Reports CPX-351 Shows Anti-Cancer Activity in Leukemia Patients

11/28/2007
Frederick R. Appelbaum, M.D. and Ross C. Donehower, M.D. Join Scientific Advisory Board of Celator® Pharmaeuticals

10/26/2007
Celator® Pharmaceuticals Study Shows CPX-571 Maintains Synergistic Ratio of Irinotecan and Cisplatin to Improve Anti-tumor Activity

10/9/2007
Celator® Announces Two Additions to Senior Management Team

8/2/2007
Celator® Closes $10 Million Follow-On Financing

6/4/2007
Celator® Pharmaceuticals Study Shows Anti-Tumor Activity in Cancer Patients Treated with Therapy Based on Ratiometric Dosing

 

 

News Links:
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
Upcoming Events

 

 

 

 

 

 
© 2009 Celator Pharmaceuticals, Inc. All rights reserved. Celator®, Celator Pharmaceuticals®, the Celator logo and CombiPlex® are registered trademarks of Celator Pharmaceuticals, Inc. Contact webmaster.